Robin Sebastian
Family Medicine · Emmett, IDNPI 1568559029
Payments from drug & device makers
Across 82 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$254
- Novartis$164
- AbbVie$124
- Pfizer$108
- AstraZeneca$87
- Lilly USA, LLC$84
- plus $600 from 19 others
What the payments were for
- Food & beverage$1,38998%
- Education$322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $254 |
| Novartis | 9 | $164 |
| AbbVie(2 entities) | 6 | $124 |
| Pfizer | 6 | $108 |
| AstraZeneca | 5 | $87 |
| Lilly USA, LLC | 6 | $84 |
| Mylan Specialty L.p. | 4 | $80 |
| Bayer | 4 | $70 |
| Amgen | 3 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $40 |
| Boehringer Ingelheim | 2 | $37 |
| Exact Sciences | 2 | $33 |
| GSK | 2 | $31 |
| Viatris Specialty LLC | 1 | $22 |
| Lucid Diagnostics Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
How this compares
$1,421 in reported general payments places this provider in the 75th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $70,963 |
| OzempicSemaglutide | 47 | $51,521 |
| MounjaroTirzepatide | 47 | $50,434 |
| FarxigaDapagliflozin Propanediol | 30 | $37,148 |
| RybelsusSemaglutide | 25 | $25,149 |
| JanuviaSitagliptin Phosphate | 11 | $15,551 |
| JardianceEmpagliflozin | 11 | $14,911 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $14,175 |
| Arnuity ElliptaFluticasone Furoate | 27 | $10,221 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $9,553 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $8,816 |
| XareltoRivaroxaban | 13 | $7,451 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $4,487 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $2,427 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $2,315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $254 | $76,66972 claims |
| PfizerEliquis | $108 | $70,96381 claims |
| Lilly USA, LLCMounjaro | $84 | $50,43447 claims |
| AstraZenecaFarxiga | $87 | $37,14830 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta, Anoro Ellipta | $31 | $33,21255 claims |
| Boehringer IngelheimJardiance | $37 | $14,91111 claims |
| Johnson & JohnsonXarelto | $16 | $7,45113 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $40 | $4,48711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 803 family medicine providers in Idaho.
Other family medicine in Emmett
- Tina McGuffeyEmmett$8K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
- Flint PackerIdaho Falls$587K
- Paul BeckettBlackfoot$344K
- Elaine DavidsonMeridian$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.